Automation software company UiPath (NYSE: PATH) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 13.6% year on year to $481.1 million. Guidance for next quarter’s revenue was better than expected at $397.5 million at the midpoint, 0.7% above analysts’ estimates. Its non-GAAP profit of $0.30 per share was 17.8% above analysts’ consensus estimates.

Is now the time to buy PATH? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

UiPath’s fourth quarter results surpassed Wall Street’s revenue and non-GAAP profit expectations, but the market responded negatively as concerns emerged around the sustainability of growth and the evolving automation landscape. Management pointed to robust enterprise adoption of its agentic automation platform, particularly AI-driven solutions, and highlighted strong sequential gains in large customer deals. CEO Daniel Dines emphasized, “We posted our strongest sequential net additions of customers with $1 million or more in ARR in 2 years,” crediting improved sales execution and deepening platform adoption across key verticals such as healthcare and financial services.

Looking to the next quarter, management attributes its guidance to continued AI adoption within its installed base, expansion in regulated verticals, and operational discipline supporting higher margins. CFO Ashim Gupta noted, “AI and agentic is going to lead the way,” while also referencing prudent assumptions in response to a variable macroeconomic environment. The company expects growth in SaaS offerings to drive recurring revenue, but highlighted that fluctuations in sectors like public sector and international markets could temper near-term acceleration. Management remains focused on scaling AI solutions, expanding into mission-critical workflows, and executing on its long-term margin targets.

Key Insights from Management’s Remarks

Management attributed the quarter’s performance to increased adoption of agentic and AI-powered automation, deeper industry vertical engagement, and improved operational discipline.

• AI-powered platform traction: Management stressed that customers are rapidly layering AI-based solutions—such as agentic automation and Maestro orchestration—on top of core automation. This contributed to higher platform stickiness and larger deals, especially among enterprises with complex workflows.
• Enterprise customer expansion: The company highlighted a significant increase in customers with $1 million or more in annual recurring revenue, reflecting deeper penetration in financial services, healthcare, and federal agencies. Management noted that 90% of its largest customers now use AI products, which management sees as a flywheel for future growth.
• Vertical solutions investment: UiPath doubled down on vertical-specific offerings, acquiring WorkFusion to enhance its compliance capabilities for financial institutions and launching healthcare-focused AI solutions for revenue cycle management and claims processing. These targeted solutions are designed to address high-stakes, regulated workflows.
• Operational efficiency gains: The company achieved its first full year of GAAP profitability, attributing margin expansion to disciplined cost control, internal adoption of its own agentic tools, and stronger global sales coordination. Management raised its long-term non-GAAP operating margin target to 30%.
• Partner ecosystem momentum: Expanded partnerships with firms like Deloitte and Accenture led to joint solutions and broader adoption of UiPath’s platform, particularly in large-scale ERP migrations and complex process automation projects. These alliances support the company’s strategy to scale enterprise-grade automation globally.

Drivers of Future Performance

UiPath’s outlook is shaped by ongoing AI adoption, disciplined cost management, and expansion in regulated industries, but management remains cautious due to macroeconomic variability.

• AI and agentic adoption: Management believes future revenue growth will be driven by the increasing integration of AI-driven automation across its enterprise base. They cited rising demand for agentic products and Maestro orchestration, with a growing backlog of automation use cases that AI is expected to unlock. However, they noted that most customers are layering AI on top of existing automation, rather than replacing it.
• Margin expansion focus: UiPath expects improved operating margins through both continued internal use of its own automation tools and cost discipline across engineering, G&A, and sales functions. CFO Ashim Gupta highlighted that the company’s long-term non-GAAP operating margin target was raised to 30%, supported by productivity gains from agentic adoption company-wide.
• Variable market environment: Despite pockets of strength in sectors like healthcare, financial services, and public sector, management characterized the broader demand environment as variable. Geopolitical uncertainty, particularly in markets like the Middle East, and currency fluctuations are cited as ongoing risks that could impact the pace of ARR and revenue growth in coming quarters.

Catalysts in Upcoming Quarters

Moving forward, the StockStory team will closely monitor (1) the pace of AI-driven automation adoption within large enterprise accounts, (2) the effectiveness of newly launched vertical solutions in healthcare and financial services, and (3) margin progression as internal productivity initiatives and cost discipline are executed. Execution on product roadmap milestones—particularly around Maestro orchestration and coding agents—will also be important signposts.

UiPath currently trades at $11.29, down from $12.46 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free).

Stocks That Trumped Tariffs

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it's flagging for this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.